Bezos backs startup aimed at delaying age-related diseases

( By Julie Spitzer for Becker’s Hospital Review)

Among the investors backing Unity Biotechnology, a startup that aims to develop drugs to extend the human lifespan, is Amazon founder and CEO Jeff Bezos, CNBC reports. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or


Leave a Reply